Vol. 20 • Na. N1 • February 2018

In this issue:

• Treatment Expansion for Opioid Use Disorders in the United States
  Parrino M.
• Capgras Syndrome in a Heroin Addict. A Case Study
  Lovrecic M., and Lovrecic B.
• Opioid Maintenance Therapy with Methadone and Levomethadone - Sexual Dysfunction and Treatment Satisfaction
  Schoofs N., Häbel T.H., Bermpohl F., and Gutwinski S.
• On the Long-Term Status of Treatment-Seeking, Heroin Addicted Patients: A 22-Year Follow-up Study on Mortality and Drug Use in Portugal
  Pombo S., and Félix da Costa N.
• Methadone Versus Torture: The Perspective of the European Court of Human Rights
  Junod V., Wolff H., Scholten W., Novet B., Greifinger R., Dickson C., and Simon O.
• Characteristics of Methadone-Related Overdose Deaths and Comparisons between Those Dying on and Off Opioid Agonist Treatment (OAT): a National Cohort Study.
  Van Hout M.C., Crowley D., Collins C., Barry A., Lyons S., and Delargy I.

Vol. 20 • Na. N2 • April 2018

In this issue:

• Methadone Dose as a Determinant of Infant Outcome During the Peri and Postnatal Period
  Wang M., Stapleton J., and Wolff K.
• Affective Temperaments in Non-Depressed Patients with Alcohol and Opiate Addictions. Is the “Dark Side” Associated with Current Depressive Symptoms?
  Kałwa A., Siwy-Hudowska A., and Niznikiewicz M.
• Heroin Deaths in Norway in 2000 and 2009: A Comparative Study of Polydrug Use
  Karinen R., Konstantinova-Larsen S., Normann P.T., Mørland J., Christophersen A.S., and Arnestad M.
• Refractory Bipolar Patient Treated with Oral Methadone: Does Methadone Act as Mood Stabilizer?
  Etaee F., Shirdel S., Azarhomayoun A., Nasiri K., and Komaki A.
• Excess Suicide Mortality in Heroin Use Disorder Patients Seeking Opioid Agonist Treatment in Slovenia and Risk Factors for Suicide
  Lovrecic M., Lovrecic B., Maremmani I., and Maremmani A.G.I.
• How to Improve a Poorly Running Agonist Opioid Treatment (Aot). Part 5: Higher Dosage
  Ulmer A., and Meinhold C.

Vol. 20 • Na. NS1 • May 2018

In this issue:

Abstract book - 13th European Congress of European Opiate Addiction Treatment Association - EUROPAD - Krakow, Poland, May 25-27, 2018

Vol. 20 • Na. N3 • June 2018

In this issue:

• The Second to Fourth Digit (2d:4d) Ratios in Patients with Heroin Use Disorder
  Canan F., Sogucak S., Karaca S., Tegin C., Gecici O., and Kuloglu M.
• Novel Psychoactive Synthetic Cannabinoids and Synthetic Cathinones: The Never-Ending Story of Potential Clinical Toxicity
  Lovrecic B., and Lovrecic M.
• Relationship between Self-Mutilative Behaviour and Novelty Seeking, the Presence of Antisocial and Borderline Personality Disorders, and Severity of Psychopathology in a Sample of Male Patients with Heroin Use Disorder
  Evren C., Karabulut V., Alniak I., Umut G., Cetin T., Evren B., and Agachanli R.
• Impact of Employment and Marital Status on Lapse Risk Situations among Addicted Patients in Methadone Maintenance Treatment
  Abed M.
• How to Develop and Implement an Exercise Programme in a Heroin-Assisted Treatment Setting
  Staub L., Gerber M., Vogel M., Dürsteler-Macfarland K., Strom J., Schoen S., Pühse U., and Colledge F.
• Diversion of Buprenorphine: Scope of the Problem and the Measures Taken to Address It
  Tripathi R., and Sarkar S.

Vol. 20 • Na. N4 • August 2018

In this issue:

• Multidisciplinary Settings in the Treatment of Drug-Addiction: An Experimental Evaluation
  Cicatelli P., Borriello M.T., De Vivo C., D'Oriano V., Fuscone A., Moccia E., and Siconolfi M.
• A Review of Literature Assessing Public Opinion of Heroin Assisted Treatment
  Berrigan P.
• Predictors of Retention and Mortality among Patients on Methadone Maintenance Therapy
  Teoh J., Yee A., and Danaee M.
• Impact of Hepatitis B(Hbv)/C(Hcv) Virus Co-Infection on the Long-Term Survival of Patients with Schizophrenia and Co-Occurring Substance Use Disorders
  Gimelfarb Y., Ligay A., and Ben Tzarfati M.
• The Cost-Effectiveness of Naloxone Programmes for the Treatment of Heroin Overdoses ‘on the Street': A 2-Year Data Collection by the Street Unit of the Villa Maraini Foundation
  Barra M., Direnzo G.F.M., Patruno F.V., Patti M., Rodoquino G., Rossi E., Santoro R., and Badiani A.
• Personality Profiles and Aggressive Behaviour of Heroin Use Disorder Patients Compared with Non-Substance-Use Peers
  Conversano C., Belcari I., Marchi L., Maremmani A.G.I., and Maremmani I.

Vol. 20 • Na. N5 • October 2018

In this issue:

• Addiction and self-reported associated sociodemographic factors in a small province of Iran
  Sedaghat Z., Fararouei M., Shahraki G., Karimzadeh Shirazi K., and Haghighi R.E.
• An evaluation of community pharmacist perception of the misuse and abuse of over-the-counter co-codamol in Cornwell and Devon, UK: a cross-sectional survey
  Barrett R., and Costa D.
• Switching between lyophilized and sub-lingual buprenorphine formulations in opioid-dependent patients: Observations on medication transfer during a safety and pharmacokinetic study
  Reed K., Knight A., Baillie S., Bogdanowicz K., Bell J., and Strang J.
• The SCL90-Based psychopathological structure may be applied in substance use disorder patients independently of the drug involved, even in heroin, alcohol and cocaine monodrug users
  Carbone M.G., Maiello M., Spera V., Manni C., Pallucchini A., Maremmani A.G.I., and Maremmani I.
• Comparing neurocognitive function in individuals receiving chronic methadone or buprenorphine for the treatment of opioid dependence: A systematic review.
  Hill D., Garner D., and Baldacchino A.
• Medicinal products detected as novel psychoactive substances: The case of intravenous use of tropicamide.
  van Hout M.C.

Vol. 20 • Na. NS2 • October 2018

In this issue:

Abstract book - 2nd World Congress of World Association on Dual Disorder - WADD - Florence, Italy, October 25-27, 2018

Vol. 20 • Na. N6 • December 2018

In this issue:

• The Pros and Cons of Supervised Urine Tests in Opioid Maintenance Treatment: A Study of Patients' Experiences
  Monwell B., Bülow P., and Johnsson B.
• ‘You Should Be Helping Him, He's Trying to Do Something About It': The Dilemma of Heroin Use, Agonist Opioid Treatment and Employment
  Emmerson O., Parkman T., Akhtar S., Lowe E., and Day E.
• Sleep Problems among Intravenous and Non-Intravenous Opioid-Dependent Patients: The Role of Modality of Use
  Khazaie H., Jalali A., Cheraghi K., Mojtaba Ahmadi S., and Khaledi-Paveh B.
• Outbreak of 'Novel Synthetic Opioids': A Deadly Threat to Public Health
  Lovrecic B., and Lovrecic M.
• Personality Dimensions and Main Drug of Use in Dual Disorders
  Hurtado Ruiz M.G., Fonseca F., Díaz Digón L., Martínez Riera R., Martínez Sanvisens D., Mateu Codina G.A., Farre Martínez A., Sauras Quetcuti R.B., and Torrens M.